• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与行保乳手术的女性切缘阳性相关的因素。

Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.

机构信息

Department of Surgery, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.

Department of Surgery, Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.

DOI:10.1016/j.mayocp.2017.11.023
PMID:29439832
Abstract

OBJECTIVE

To identify factors predicting positive margins at lumpectomy prompting intraoperative reexcision in patients with breast cancer treated at a large referral center.

PATIENTS AND METHODS

We reviewed all breast cancer lumpectomy cases managed at our institution from January 1, 2012, through December 31, 2013. Associations between rates of positive margin and patient and tumor factors were assessed using χ tests and univariate and adjusted multivariate logistic regression, stratified by ductal carcinoma in situ (DCIS) or invasive cancer.

RESULTS

We identified 382 patients who underwent lumpectomy for definitive surgical resection of breast cancer, 102 for DCIS and 280 for invasive cancer. Overall, 234 patients (61.3%) required intraoperative reexcision for positive margins. The reexcision rate was higher in patients with DCIS than in those with invasive disease (78.4% [80 of 102] vs 56.4% [158 of 280]; univariate odds ratio, 2.80; 95% CI, 1.66-4.76; P<.001). Positive margin rates did not vary by patient age, surgeon, estrogen receptor, progesterone receptor, or ERBB2 status of the tumor. Among the 280 cases of invasive breast cancer, the only factor independently associated with lower odds of margin positivity was seed localization vs no localization (P=.03).

CONCLUSION

Ductal carcinoma in situ was associated with a higher rate of positive margins at lumpectomy than invasive breast cancer on univariate analysis. Within invasive disease, seed localization was associated with lower rates of margin positivity.

摘要

目的

确定在大型转诊中心治疗的乳腺癌患者中,保乳手术后切缘阳性预测因素,以促使术中再次切除。

方法

我们回顾了 2012 年 1 月 1 日至 2013 年 12 月 31 日期间在我院接受保乳手术的所有乳腺癌病例。使用 χ 检验和单变量及调整后的多变量逻辑回归评估切缘阳性率与患者和肿瘤因素之间的关系,并按导管原位癌 (DCIS) 或浸润性癌分层。

结果

我们确定了 382 例接受保乳术治疗乳腺癌的患者,其中 102 例为 DCIS,280 例为浸润性癌。总体而言,234 例 (61.3%)患者因切缘阳性需要术中再次切除。DCIS 患者的再次切除率高于浸润性疾病患者 (78.4% [80/102] vs 56.4% [158/280];单变量优势比,2.80;95%CI,1.66-4.76;P<.001)。切缘阳性率与患者年龄、外科医生、雌激素受体、孕激素受体或肿瘤 ERBB2 状态无关。在 280 例浸润性乳腺癌病例中,唯一与切缘阳性率较低独立相关的因素是种子定位与无定位 (P=.03)。

结论

在单变量分析中,DCIS 与保乳手术后切缘阳性率高于浸润性乳腺癌相关。在浸润性疾病中,种子定位与较低的切缘阳性率相关。

相似文献

1
Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.与行保乳手术的女性切缘阳性相关的因素。
Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.
2
Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.新的保乳手术切缘指南对保乳手术的影响:再次切除率及残余肿瘤预测率的变化
Ann Surg Oncol. 2016 Mar;23(3):729-34. doi: 10.1245/s10434-015-4916-2. Epub 2015 Oct 14.
3
Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.早期采用美国放射肿瘤学会(ASTRO)关于Ⅰ期和Ⅱ期浸润性乳腺癌保乳手术切缘及全乳照射的共识指南:纪念斯隆凯特琳癌症中心的初步经验
Ann Surg Oncol. 2016 Oct;23(10):3239-46. doi: 10.1245/s10434-016-5397-7. Epub 2016 Jul 12.
4
The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.保乳手术治疗乳腺癌后,再次切除切缘阳性组织在优化局部疾病控制方面的作用。
Breast J. 2006 Jul-Aug;12(4):331-7. doi: 10.1111/j.1075-122X.2006.00271.x.
5
Ductal carcinoma in situ: size and resection volume predict margin status.导管原位癌:大小和切除体积预测切缘状态。
Am J Clin Oncol. 2010 Oct;33(5):438-42. doi: 10.1097/COC.0b013e3181b9cf31.
6
Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.导线引导下保乳手术后导管原位癌与浸润性乳腺癌的再次手术率
JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751.
7
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study.大视场共聚焦激光扫描显微镜对保乳术表面成像用于术中切缘评估-POLARHIS 研究。
Breast. 2022 Dec;66:118-125. doi: 10.1016/j.breast.2022.10.003. Epub 2022 Oct 5.
8
Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.保乳手术后手术切缘的预测因素:一项基于大样本人群的队列研究。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):627-633. doi: 10.1245/s10434-016-5532-5. Epub 2016 Sep 2.
9
Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?导管原位癌的体积是否会影响接受保乳术治疗浸润性乳腺癌患者的阳性切缘率?
J Surg Res. 2013 Sep;184(1):228-33. doi: 10.1016/j.jss.2013.03.071. Epub 2013 Apr 8.
10
Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.新的“肿瘤无墨水”乳房肿瘤切除术切缘指南是否应应用于导管原位癌(DCIS)?一项使用刮除腔切缘的回顾性研究。
Ann Surg Oncol. 2016 Oct;23(11):3453-3458. doi: 10.1245/s10434-016-5251-y. Epub 2016 May 20.

引用本文的文献

1
Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?联盟ACOSOG Z11102的真实世界应用:可避免多少患者接受乳房切除术?
Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18344-z.
2
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patients.人工智能驱动的可视化软件平台在乳腺癌患者精准手术中的性能
NPJ Breast Cancer. 2024 Nov 14;10(1):98. doi: 10.1038/s41523-024-00696-6.
3
Radioactive Seed Localization for Nonpalpable Breast Lesions: Systematic Review and Meta-Analysis.
不可触及乳腺病变的放射性粒子定位:系统评价与Meta分析
Diagnostics (Basel). 2024 Feb 17;14(4):441. doi: 10.3390/diagnostics14040441.
4
Risk Factors for Positive Margins in Breast-Conserving Surgery.保乳手术切缘阳性的危险因素。
Cureus. 2023 May 1;15(5):e38399. doi: 10.7759/cureus.38399. eCollection 2023 May.
5
Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?保乳手术后导管原位癌的阳性切缘:组织学分级或雌激素受体状态重要吗?
Breast Cancer Res Treat. 2023 Jun;199(2):215-220. doi: 10.1007/s10549-023-06905-3. Epub 2023 Apr 7.
6
Tissue-mimicking phantom materials with tunable optical properties suitable for assessment of diffuse reflectance spectroscopy during electrosurgery.具有可调光学特性的组织模拟体模材料,适用于评估电外科手术期间的漫反射光谱。
Biomed Opt Express. 2022 Apr 4;13(5):2616-2643. doi: 10.1364/BOE.449637. eCollection 2022 May 1.
7
Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).在纯导管原位癌(DCIS)保乳治疗中,肿瘤大小的放射学低估作为切缘阳性率的相关危险因素。
Cancers (Basel). 2022 May 11;14(10):2367. doi: 10.3390/cancers14102367.
8
Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.光学组织测量浸润性癌和导管原位癌以指导手术。
Breast Cancer Res. 2021 May 22;23(1):59. doi: 10.1186/s13058-021-01436-5.
9
Oncoplastic Breast-Conserving Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy Use in Patients with Traditional Indications for Mastectomy?肿瘤整形保乳手术:对于有传统乳房切除术指征的患者,我们能否降低乳房切除术和化疗的使用比例?
Ann Surg Oncol. 2021 Apr;28(4):2199-2209. doi: 10.1245/s10434-020-09044-x. Epub 2020 Sep 28.
10
Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.保乳手术治疗导管原位癌的再次切除术预测因素。
Ann Surg Oncol. 2021 Mar;28(3):1390-1397. doi: 10.1245/s10434-020-09101-5. Epub 2020 Sep 10.